Showing results (101-110 of 539) with videos related to
Sort By:
Pageof 54
Animals : an Open Access Journal From MDPI|July 14, 2023
Canine Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Atopic DermatitisByong Seung Cho, Sung-Bae Kim, Sokho Kim, et al.Journal of Breast Cancer|January 16, 2016
Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative IISung-Bae Kim, Yau Tsz Kok, Tran Van Thuan, et al.Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 16, 2012
Spectroscopic studies of the color modulation mechanism of firefly (beetle) bioluminescence with amino-analogs of luciferin and oxyluciferinTakashi Hirano, Hiroyuki Nagai, Takuto Matsuhashi, et al.Human Pathology|August 30, 2006
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesMi-Jung Kim, Jae Y Ro, Sei-Hyun Ahn, et al.The Laryngoscope|February 19, 2013
Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neckYunsuk Choi, Sung-Bae Kim, Dok Hyun Yoon, et al.Photochemistry and Photobiology|June 3, 2021
Absorption Spectra for Firefly Bioluminescence Substrate Analog: TokeOni in Various pH SolutionsHaruhisa Ogawa, Ryohei Ono, Yoshifumi Noguchi, et al.Cancer Research and Treatment|June 27, 2021
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.Future Oncology (London, England)|August 22, 2019
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from AsiaBinghe Xu, Sung-Bae Kim, Kenichi Inoue, et al.Cancer Research and Treatment|March 30, 2021
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA TrialKyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, et al.Chemical Communications (Cambridge, England)|February 1, 2018
An allylated firefly luciferin analogue with luciferase specific response in living cellsYuma Ikeda, Tsuyoshi Saitoh, Kazuki Niwa, et al.Pageof 54